A detailed history of Simplify Asset Management Inc. transactions in Argenx Se stock. As of the latest transaction made, Simplify Asset Management Inc. holds 2,419 shares of ARGX stock, worth $1.55 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,419
Previous 2,419 -0.0%
Holding current value
$1.55 Million
Previous $1.31 Million -0.0%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$434.22 - $551.9 $409,903 - $520,993
944 Added 64.0%
2,419 $1.31 Million
Q2 2024

Aug 12, 2024

BUY
$356.01 - $451.55 $525,114 - $666,036
1,475 New
1,475 $634,000
Q4 2023

Feb 12, 2024

SELL
$338.91 - $506.01 $427,026 - $637,572
-1,260 Reduced 41.47%
1,778 $676,000
Q3 2023

Nov 14, 2023

SELL
$369.35 - $548.43 $12,927 - $19,195
-35 Reduced 1.14%
3,038 $1.49 Million
Q2 2023

Aug 14, 2023

BUY
$360.14 - $422.58 $1.11 Million - $1.3 Million
3,073 New
3,073 $1.2 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $35.4B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Simplify Asset Management Inc. Portfolio

Follow Simplify Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.